Respiratory tumours are a major part of daily practice for many respiratory physicians. Lung cancer is the biggest cancer killer in Europe today – a pandemic of the 20th and 21st century due to exposure to new causative agents combined with increasing lifespan.
There have been significant developments in surgery, chemotherapy and radiotherapy, but still seven out of eight people die within five years of diagnosis. The most recent advances, however, focus on understanding the biology of lung cancer and are leading to promising new targeted therapies.
You can stay up to date on the topic of thoracic oncology by joining us at this year's Congress in Milan, as this year's programme includes a variety of scientific sessions and educational activites focussing on topics related to throacic oncology.